![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Altman D, Väyrynen T, Engh ME, Axelsen S, Falconer C. Nordic Transvaginal Mesh Group. 2011. Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. The new England Journal of Medicine 364:1826–1836.
- Beck RP, McCormick S, Nordstrom L. 1991. A25-year experience with 519 anterior colporrhaphy procedures. Obstetrics and Gynecolology 78:1011–1018.
- Benson JT, Lucente V, McClellan E. 1996. Vaginal versus abdominal reconstructive surgery for the treatment of pelvic support defects: a prospective randomized study with long-term outcome evaluation. American Journal of Obstetrics & Gynecology 175:1418–1421.
- Boyles SH, McCrery R. 2008Dyspareunia and mesh erosion after vaginal mesh placement with a kit procedure. Obstetrics and Gynecolology 111:969–975
- Clark AL, Gregory T, Smith VJ, Edwards R. 2003. Epidemiologic evaluation of reoperation for surgically treated pelvic organ prolapse and urinary incontinence. American Journal of Obstetrics & Gynecology 189:1261–1267.
- Dällenbach P, Jungo Nancoz C, Eperon I, Dubuisson JB, Boulvain M. 2012. Incidence and risk factors for reoperation of surgically treated pelvic organ prolapse. International Urogynecology Journal 23:35–41.
- Davila GW, Baessler K, Cosson M, Cardozo L.Selection of patients in whom vaginal graft use may be appropriate: Consensus of the 2nd IUGA Grafts Roundtable: Optimizing Safety and Appropriateness of Graft Use in Transvaginal Pelvic Reconstructive Surgery. 2012. International Urogynecology Journal; 23 Suppl 1:7–14.
- FDA Safety Communication: UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse. 2008. http://www.fda.gov/MedicalDevices/Safety/ AlertsandNotices/ucm262435.htm
- Hiltunen R, Nieminen K, Tarala T, Heiskanen E, Merikari M, Niemi K et al. 2007. Low-weight polypropylene mesh for anterior vaginal wall prolapse: a randomized controlled trial. Obstetrics and Gynecolology 110:455–462
- Kjølhede P, Norén B, Rydén G. 1996. Prediction of genital prolapse after Burch colposuspension. Acta Obstetricia et Gynecologica Scandinavica 75:849–854.
- Maher C, Feiner B, Baessler K, Schmid C. 2013. Surgical management of pelvic organ prolapse in women.Cochrane Database of Systematic Reviews 30;4.
- Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. 1997. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstetrics and Gynecolology 89:501–506.
- Peterson TV, Karp DR, Aguilar VC, Davila GW. 2010. Primary versus recurrent prolapse surgery: differences in outcomes. International Urogynecology Journal 21:483–488
- Rane A, Iyer J, Kannan K, Corstiaans A.2012. Prospective study of the Perigee™ system for treatment of cystocele - our five-year experience. Australian and New Zealand Journal of Obstetrics and Gynaecology 52:28–33.
- Salvatore S, Athanasiou S, Digesu GA, Soligo M, Sotiropoulou M, Serati M et al. 2009Identification of risk factors for genital prolapse recurrence. Neurourology and Urodynamics 28:301–304.
- Wiskind AK, Creighton SM, Stanton SL. 1992. The incidence of genital prolapse after the Burch colposuspension American Journal of Obstetrics & Gynecology 167:399–404.
- Withagen MI, Milani AL, de Leeuw JW, Vierhout ME. Development of de novo prolapse in untreated vaginal compartments after prolapse repair with and without mesh: a secondary analysis of a randomised controlled trial.2012. An International Journal of Obstetrics & Gynaecology 119:354–360.